Time taken by individuals with respiratory symptoms to present to primary care: a descriptive study of assessments at Australian General Practitioner-led respiratory clinics
DOI:
https://doi.org/10.33321/cdi.2022.46.20Keywords:
COVID-19, Coronavirus disease 2019, SARS-CoV-2, respiratory symptoms, primary health care, public health response, testing, AustraliaAbstract
Effective control of coronavirus disease 2019 (COVID-19) has been challenging, in part due to significant asymptomatic and pre-symptomatic transmission of disease. Reducing the time between symptom onset and COVID-19 testing and isolation allows enhanced outbreak control. The purpose of this study is to describe the time taken by participants to present to general practitioner-led (GP) respiratory clinics for assessment following the development of symptoms, and to explore associations between demographic and geographic characteristics and the time to presentation.
A total of 314,148 participants, who were assessed in GP respiratory clinics between 1 February and 31 August 2021, were included in the analysis. The median age of participants at presentation was 33 years (interquartile range, IQR: 15–49).
The median time from development of symptoms to presentation for assessment at GP respiratory clinics was 2 days (IQR: 1–3). Participants were more likely to present within one day of symptom onset if they were aged between 15 and 64 years (43.4%), lived in urban areas (40.9%) or were non-Indigenous (40.2%). Participants in New South Wales and Victoria had twice the odds (OR 2.01; 95% confidence interval (CI): 1.95, 2.08) of presenting at a GP respiratory clinic within one day of symptom onset in August 2021, when there was a COVID-19 outbreak in those states, than they did in March 2021, when there was no COVID-19 outbreak in Australia.
The number of days from symptom onset to presentation at a GP respiratory clinic was strongly associated with the presence of a COVID-19 outbreak. Participant age, location of the clinic, and Indigenous status of participants were also associated with the time to presentation. This study highlights the importance of recognising COVID-19 as a potential cause of symptoms, as well as the importance of providing easily accessible, and culturally appropriate, testing facilities for the population.
Downloads
References
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: https://doi.org/10.1016/S0140-6736(20)30183-5.
Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Presymptomatic transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):411–5. doi: https://doi.org/10.15585/mmwr.mm6914e1.
Xin H, Li Y, Wu P, Li Z, Lau EHY, Qin Y et al. Estimating the latent period of coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021. doi: https://doi.org/10.1093/cid/ciab746.
Bae S, Lim JS, Kim JY, Jung J, Kim S-H. Transmission characteristics of SARS-CoV-2 that hinder effective control. Immune Netw. 2021;21(1). doi: https://doi.org/10.4110/in.2021.21.e9.
He X, Lau EHY, Wu P, Deng X, Wang J, Hao X et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672–5. doi: https://doi.org/10.1038/s41591-020-0869-5.
Casey-Bryars M, Griffin J, McAloon C, Byrne A, Madden J, Mc Evoy D et al. Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data. BMJ Open. 2021;11(6):e041240. doi: https://doi.org/10.1136/bmjopen-2020-041240.
Johansson MA, Quandelacy TM, Kada S, Prasad PV, Steele M, Brooks JT et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021;4(1):e2035057-e. doi: https://doi.org/10.1001/jamanetworkopen.2020.35057.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH et al. The implications of silent transmission for the control of COVID-19 outbreaks. Proc Natl Acad Sci U S A. 2020;117(30):17513–5. doi: https://doi.org/10.1073/pnas.2008373117.
Australian Government Department of Health, Communicable Diseases Network Australia (CDNA). Coronavirus disease 2019 (COVID-19): CDNA national guidelines for public health units. [Internet.] Canberra: Australian Government Department of Health; 2021. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-novel- coronavirus.htm.
Australian Government Department of Health. What you need to know about coronavirus (COVID-19): how to get tested. [Internet.] Canberra: Australian Government Department of Health; 11 August 2021. Available from: https://www.health.gov.au/news/health-alerts/novel-coronavirus-2019-ncov-health-alert/ongoing-support-during-coronavirus-covid-19/what-you-need-to-know-about-coronavirus-covid-19#how-to-get-tested.
Reddy KP, Shebl FM, Foote JHA, Harling G, Scott JA, Panella C et al. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet Glob Health. 2021;9(2):e120–9. doi: https://doi.org/10.1016/S2214-109X(20)30452-6.
Kretzschmar ME, Rozhnova G, Bootsma MCJ, van Boven M, van de Wijgert JHHM, Bonten MJM. Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study. Lancet Public Health. 2020;5(8):e452–9. doi: https://doi.org/10.1016/S2468-2667(20)30157-2.
Department of the Prime Minister and Cabinet. Media release: 11 Mar 2020. Canberra: Australian Government Department of the Prime Minister and Cabinet; 11 March 2020. Available from: https://www.pm.gov.au/media/24-billion-health-plan-fight-covid-19#:~:text=The%20Australian%20Government%20has%20unveiled,coronavirus%20(COVID%2D19).
Australian Government Department of Health. Coronavirus (COVID-19) GP respiratory clinics. [Internet.] Canberra: Australian Government Department of Health; 9 October 2020. Available from: https://www.health.gov.au/initiatives-and-programs/coronavirus-covid-19-gp-respiratory-clinics.
StataCorp. Stata: Release 17. Statistical Software. College Station, TX: StataCorp LLC; 2021.
Keast DH, Marshall JN, Stewart MA, Orr V. Why do patients seek family physicians’ services for cold symptoms? Can Fam Physician. 1999;45:335–40.
New South Wales Government, Agency for Clinical Innovation. COVID-19 Risk Monitoring Dashboard. [Webpage.] Sydney: New South Wales Department of Health; 2021. Available from: https://aci.health.nsw.gov.au/covid-19/critical-intelligence-unit/dashboard.
Mowbray F, Woodland L, Smith LE, Amlôt R, Rubin GJ. Is my cough a cold or covid? A qualitative study of COVID-19 symptom recognition and attitudes toward testing in the UK. Front Public Health. 2021;9:716421. doi: https://doi.org/10.3389/fpubh.2021.716421.
Rubin GJ, Smith LE, Melendez-Torres GJ, Yardley L. Improving adherence to ‘test, trace and isolate’. J R Soc Med. 2020;113(9):335–8. doi: https://doi.org/10.1177/0141076820956824.
Smith LE, Potts HWW, Amlôt R, Fear NT, Michie S, Rubin GJ. Adherence to the test, trace, and isolate system in the UK: results from 37 nationally representative surveys. BMJ. 2021;372:n608. doi: https://doi.org/10.1136/bmj.n608.
Clipman SJ, Wesolowski A, Mehta SH, Cobey S, Cummings DAT, Solomon SS. Improvements in SARS-CoV-2 testing cascade in the US: data from serial cross-sectional assessments. Clin Infect Dis. 2021. doi: https://doi.org/10.1093/cid/ciab683.
Bevan I, Stage Baxter M, Stagg HR, Street A. Knowledge, attitudes, and behavior related to COVID-19 testing: a rapid scoping review. Diagnostics (Basel). 2021;11(9). doi: https://doi.org/10.3390/diagnostics11091685.
Carter P, Megnin-Viggars O, Rubin GJ. What factors influence symptom reporting and access to healthcare during an emerging infectious disease outbreak? A rapid review of the evidence. Health Secur. 2021;19(4):353–63. doi: https://doi.org/10.1089/hs.2020.0126.
Government of New South Wales. COVID-19 restrictions tightened across Greater Sydney. [Internet.] Sydney: Government of New South Wales; 9 July 2021. Available from: https://www.nsw.gov.au/media-releases/covid-19-restrictions-tightened-across-greater-sydney.
Premier of Victoria. Seven day lockdown to keep Victorians safe. [Internet.] Melbourne: Victoria State Government, Premier of Victoria; 5 August 2021. Available from: https://www.premier.vic.gov.au/seven-day-lockdown-keep-victorians-safe.
Australian Institute of Health and Welfare (AIHW). Rural & remote health. Canberra: Australian Government, AIHW; 22 October 2019. Available from: https://www.aihw.gov.au/reports/rural-remote-australians/rural-remote-health/contents/summary.
Stanley F, Langton M, Ward J, McAullay D, Eades S. Australian First Nations response to the pandemic: a dramatic reversal of the ‘gap’. J Paediatr Child Health. 2021. doi: https://doi.org/10.1111/jpc.15701.
He B, Zaidi S, Elesedy B, Hutchinson M, Paleyes A, Harling G et al. Effectiveness and resource requirements of test, trace and isolate strategies for COVID in the UK. R Soc Open Sci. 2021;8(3):201491. doi: https://doi.org/10.1098/rsos.201491.
Department of the Prime Minister and Cabinet. National plan to transition Australia’s national COVID-19 response. Canberra: Australian Government Department of the Prime Minister and Cabinet; 6 August 2021. Available from: https://www.pm.gov.au/sites/default/files/media/national-plan-to-transition-australias-national-covid-19-response-30-july-2021.pdf.
Gupta A, Gonzalez-Rojas Y, Juarez E, Casal MC, Moya J, Falci DR et al. Early Covid-19 treatment with SARS-CoV-2 neutralizing antibody sotrovimab. N Engl J Med. 2021;385(21):1941–50. doi: https://doi.org/10.1056/NEJMoa2107934.
Published
How to Cite
License
Copyright (c) 2022 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
